Medications for Iron Deficiency Anemia
27 results
Centratex (iron, sodium ascorbate, thiamine mononitrate, riboflavin, pyridoxine hydrochloride, folic acid, cyanocobalamin, niacinamide, calcium pantothenate, zinc sulfate, magnesium sulfate, manganese sulfate, and cupric sulfate anhydrous)
(Iron, Sodium Ascorbate, Thiamine Mononitrate, Riboflavin, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Niacinamide, Calcium Pantothenate, Zinc Sulfate, Magnesium Sulfate, Manganese Sulfate, and Cupric Sulfate Anhydrous)Centurion Labs, LLC
Usage: This drug is indicated for treating anemia caused by iron and low folate deficiency, associated with conditions like menorrhagia, pregnancy, and excessive blood loss. It also addresses combined deficiencies of iron, vitamin C, and B-complex vitamins during acute or chronic illnesses and periods of metabolic stress or recovery.
Chromagen (ferrous asparto glycinate, ferrous fumarate, ascorbic acid, folic acid, cyanocobalamin, zinc, and intrinsic factor)
(ferrous asparto glycinate, ferrous fumarate, ascorbic acid, folic acid, cyanocobalamin, zinc, and intrinsic factor)Avion Pharmaceuticals, LLC
Usage: Chromagen™ is a multivitamin/multimineral dietary supplement indicated for improving the nutritional status of patients with iron deficiency.
Davimet with iron (iron, folate)
(Iron, Folate)PureTek Corporation
Usage: Davimet™ with Iron Multivitamin Chewable Tablets are indicated for treating iron deficiency anemia and folate deficiency related to conditions like pregnancy, excessive blood loss, and advanced age. They also address combined iron and vitamin C deficiencies, as well as B-Complex vitamin needs during illness and convalescence.
Deferasirox (deferasirox)
(Deferasirox)Teva Pharmaceuticals Inc
Usage: Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients 10 and older, with specific liver iron and serum ferritin levels.
Deferasirox (deferasirox)
(deferasirox)Bionpharma Inc.
Usage: Deferasirox is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for patients aged 10 and older with non-transfusion-dependent thalassemia syndromes who have specific liver iron levels and serum ferritin. Its safety with other iron chelation therapies is not established.
Deferasirox (deferasirox)
(Deferasirox)Ascend Laboratories, LLC
Usage: Deferasirox is indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron concentrations and serum ferritin levels.
Deferasirox (deferasirox)
(DEFERASIROX)Zydus Pharmaceuticals USA Inc.
Usage: Deferasirox is indicated for the treatment of chronic iron overload due to blood transfusions in patients aged 2 and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific iron concentration and serum ferritin levels.
Deferasirox (deferasirox)
(Deferasirox)Actavis Pharma, Inc.
Usage: Deferasirox tablets are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 years and older, and chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific liver iron and serum ferritin levels.
Deferasirox oral granules (deferasirox)
(deferasirox)EPIC PHARMA, LLC
Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 years and older, and for chronic iron overload in non-transfusion-dependent thalassemia syndromes in patients aged 10 years and older with specific iron levels.
Deferasorox (deferasirox)
(Deferasirox)MSN LABORATORIES PRIVATE LIMITED
Usage: Deferasirox oral granules are indicated for treating chronic iron overload due to blood transfusions in patients aged 2 and older, and for non-transfusion-dependent thalassemia syndromes in patients aged 10 and older with specific iron concentration criteria. Safety with other iron chelation therapies is not established.